Month: February 2024

NEW YORK, Feb. 27, 2024 (GLOBE NEWSWIRE) — Perella Weinberg Partners (the “Company” or “PWP”) (Nasdaq: PWP), a leading global independent advisory firm, today announced the pricing of its upsized public offering of 5,000,000 shares of Class A common stock at a public offering price of $12.00 per share (the “Offering”). In addition, the Company has granted the underwriter a 30-day option to purchase up to an additional 750,000 shares of its Class A common stock at the public offering price, less underwriting discounts and commissions. The Offering is expected to close on March 1, 2024, subject to customary closing conditions. The Company intends to contribute the net proceeds from the Offering to PWP Holdings LP (“PWP OpCo”) in exchange for 5,000,000 PWP OpCo Class A partnership units (5,750,000 PWP OpCo Class A partnership units...

MIAMI, FL, Feb. 27, 2024 (GLOBE NEWSWIRE) — Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for higher quality weight loss, oncology, and viral induced acute respiratory distress syndrome (ARDS), today announced that it received a delinquency notification letter (“Notice”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“Nasdaq”) on February 21, 2024 due to the Company’s non-compliance with Nasdaq Listing Rule 5250(c)(1) as a result of the Company’s failure to timely file its Quarterly Report on Form 10-Q for the fiscal quarter ended December 31, 2023 (the “Form 10-Q”). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission...

HAMILTON, Ontario, Feb. 27, 2024 (GLOBE NEWSWIRE) — Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a growing global healthcare technology company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, is pleased to announce that it has expanded its mental health services portfolio and expects to add 10,000 new mental health patients to its platform in 2024. “We are very pleased to be adding cognitive assessments to our portfolio of mental health services,” said Chris Shields, CEO at Reliq Health Technologies, Inc. “Many of our existing and potential clients have requested that Reliq offer additional products and services in the mental healthcare area, particularly for patients in Skilled Nursing and Assisted Living Facilities. Providing cognitive...

CHICAGO, Feb. 27, 2024 (GLOBE NEWSWIRE) — Vivid Seats Inc. (NASDAQ:SEAT) (“Vivid Seats”), a leading marketplace that utilizes its technology platform to connect millions of buyers with thousands of ticket sellers across hundreds of thousands of events each year, will report financial results for the fourth quarter and full year 2023 on Tuesday, March 5, 2024, before the U.S. stock market opens. Management will discuss the results on a webcast at 8:30 a.m. ET. The live webcast and replay can be accessed at https://investors.vividseats.com/. About Vivid Seats Founded in 2001, Vivid Seats is a leading online ticket marketplace committed to becoming the ultimate partner for connecting fans to the live events, artists, and teams they love. Based on the belief that everyone should “Experience It Live,” the Chicago-based company provides...

ROCKVILLE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) —  MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer, today announced that the Company will release its financial results for the fourth quarter of 2023 after the market closes on Thursday, March 7, 2024. MacroGenics will host a conference call to discuss the financial results and recent corporate progress on Thursday, March 7, 2024, at 4:30 pm ET. Conference Call Information To participate via telephone, please register in advance at this link. Upon registration, all telephone participants will receive a confirmation email detailing how to join the conference call, including the dial-in number along with a unique passcode and registrant ID that can...

QIAGEN Biomedical KB-AI contains over 640 million biomedical relationships, including gene, disease and drug causal relationships, to aid in data-driven drug discovery // AI-driven insights complement human-curated QIAGEN Biomedical KB-HD and help identify novel relationships between diseases, biological pathways and molecular interactions that may be missed by traditional methods // Workflow cuts down on hypothesis testing time and speeds up the identification of promising therapeutic avenues with clear, structured data Venlo, the Netherlands, and Redwood City, California, Feb. 27, 2024 (GLOBE NEWSWIRE) — QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base designed to propel drug discovery in the pharma and biotech industries. This...

Rocky Mountain Chocolate’s 2024 spring products include exciting new chocolate cream eggs, build-your-own Easter basket treats, and customer-favorite Lemon Bar Toffee DURANGO, Colo., Feb. 27, 2024 (GLOBE NEWSWIRE) — Rocky Mountain Chocolate Factory, Inc. (NASDAQ: RMCF) (“Rocky Mountain Chocolate”, the “Company,” “we” or “RMCF”), is an international franchiser and manufacturer of premium chocolates and other confectionary products with a presence in over 270 locations throughout the United States, has announced that its spring chocolate line-up for 2024 is out and available now. Spring flavors and classic Easter treats return, along with new favorites to brighten the season. Products are available through its retail stores and online for a limited time:5 Varieties of Filled Chocolate Easter...